Vaccination against coronavirus in diabetes mellitus

2024 Author: James Gerald | [email protected]. Last modified: 2023-12-17 14:00

Vaccination is one of the most discussed issues today. In particular, it is relevant how effective the coronavirus vaccine is in diabetes mellitus and whether it can harm such patients.

General indicators of the effectiveness of vaccine administration

Scientists have already learned that a good vaccine can provide the same benefits for people with normal blood sugar levels and for people with diabetes. First and foremost, the vaccine provides a reduced chance of complications if a person does become infected. It is especially important to understand the mechanisms of action of the vaccine in the case of a patient with chronic pathologies, including diabetes.

The Centers for Disease Control and Prevention around the world is conducting in-depth research in this regard. US virologists advise diabetics not to avoid vaccinations. On the contrary, they insist on vaccination against coronavirus in diabetes mellitus as one of the most effective tools for protecting human health.

According to statistics, 14% of all deaths had diseases of the endocrine system.

Diabetes is an ailment that can cause serious complications if a patient gets the flu, whooping cough, or pneumococcus. Vaccination with quality materials helps to prevent all of these risks.

Immune response in coronavirus

Italian doctors studying the mechanisms of the effect of coronavirus on patients with diabetes examined how the pathogen behaved in the body of such patients in case of hyperglycemia.

The total number of people who took part in this study is 509 people. 139 of them were diagnosed with diabetes, and more than half of them had high sugar levels before hospitalization due to coronavirus.

At the same time, 49 people were admitted to the hospital and only after that they were diagnosed with diabetes. Let's list the features that we managed to determine in relation to patients who already had the symptoms of diabetes in comparison with those who had not previously experienced an increase in glucose:

• dysfunction of the kidneys, lungs, a decrease in their functionality;
• the addition of more pronounced inflammation in comparison with those who did not have diabetes before;
• larger areas of tissue damage;
• more significant risks of complications.

The virus is a pathogenic microorganism that is perceived by the immune system as a foreign component. As soon as it enters organs and tissues, the immune system immediately starts producing antibodies.

Specific proteins are formed, the task of which is the timely detection and neutralization of viruses. The more such proteins are present in the body, the more chances a person has to endure the disease easily and without complications.

Modern research has shown that the immune response in coronavirus has nothing to do with an increase in blood sugar. Sometimes there may be slight differences between people with and without diabetes, but this is not often the case.

It turns out that hyperglycemia does not have a depressing effect on the level of antibodies against coronavirus. At the same time, the presence of antibodies of the IgG type, which form the outer layer of the pathogen, is associated with rather good protective effects.

Other nuances

It was also possible to establish a connection between hyperglycemia, diabetes and the formation of pneumonia of a coronavirus nature. In particular, it was found that hyperglycemia was independently associated with more pronounced clinical manifestations of coronavirus.

Also, in the case of the addition of other chronic diseases and amenable to control of blood sugar, a milder form of the disease was subsequently observed. The most susceptible to complications were patients in whom sugar did not respond well to drug adjustment.

Thus, when it comes to pneumonia as a potential complication of coronavirus, the control of hyperglycemia plays an essential role. That is, the prognosis will also directly depend on how responsibly a person with diabetes will treat the treatment prescribed by an endocrinologist.

Patients who have not officially received a confirmed diagnosis of diabetes, but who periodically have increased sugar, more often dealt with severe symptoms of coronavirus, the addition of pneumonia. Weakening, problems with an adequate response of the immune system, and concomitant illnesses contributed to this.

In search of an answer, whether or not diabetics can be vaccinated with coronavirus, it turns out that regardless of the antibody response, patients without diabetes are still slightly more likely to survive the disease without complications than with an elevated blood sugar level. The most dangerous coronavirus is for people who have high sugar that is difficult to treat, as well as additional concomitant diseases.

Outcomes

1. People with diabetes are at risk of being more likely to face complications from the coronavirus.
2. For this reason, they are advised to get vaccinated first in order to avoid such adverse situations.
3. It is especially important to take advantage of vaccination if the patient has difficulties with normalizing blood sugar levels.